June 25, 2012 — The first 10 cardiac catheterization laboratories to undergo review by Accreditation for Cardiovascular Excellence (ACE) all welcomed the evaluation by outside experts. Still, review teams found insufficiencies in record-keeping and other quality metrics at well-run medical centers, according to two studies presented at the recent Society for Cardiovascular Angiography and Interventions (SCAI) 2012 Scientific Sessions.
June 25, 2012 — Among six large integrated healthcare systems between 1996 and 2010 there was a substantial increase in the use of advanced diagnostic imaging, according to a study in the Journal of the American Medical Association (JAMA).
June 22, 2012 — In a recently approved position statement, the American Association of Physicists in Medicine (AAPM) affirms that computed tomography (CT) scans are important diagnostic tools for children and adults when used appropriately.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 22, 2012 — Vital Images Inc., a Toshiba Medical Systems Group company, has been recognized by J.D. Power and Associates for the third consecutive year.
June 22, 2012 — Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) has cleared the Somatom Perspective, an advanced 128-slice computed tomography (CT) scanner engineered to drive efficiency and reduce costs.
June 22, 2012 — Philips introduced the iDose4 Premium Package, which includes two technologies that can improve image quality: the iDose4 iterative reconstruction technique, and metal artifact reduction for large orthopedic implants (O-MAR).
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 22, 2012 — The University of Miami Miller School of Medicine’s Interdisciplinary Stem Cell Institute (ISCI) announced that it received a $10 million grant from The Starr Foundation, one of the largest private foundations in the United States.
June 22, 2012 –– The U.S. Food and Drug Administration (FDA) recently selected a stent graft being developed by Medtronic Inc. for an early feasibility pilot program that allows for “early clinical evaluation to provide proof of principle and initial clinical safety data.”
June 22, 2012 — Bayer HealthCare widens its portfolio of interventional solutions by introducing the Jetstream Navitus L Atherectomy Catheter. Positioned as the largest diameter rotational atherectomy device in the Jetstream catheter family, the Navitus L catheter can create a lumen 30 percent larger than the standard Navitus device.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
June 22, 2012 — Bayer HealthCare’s Radiology and Interventional unit has launched the new Mark 7 Arterion Injection System, the latest in the Medrad Mark series of angiographic injectors.

June 22, 2012 — The the U.S. Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee voted in May against recommending approval of expanding the indication for rivaroxaban (Xarelto) for the reduction of the risk of secondary cardiovascular events in patients with acute coronary syndrome (ACS).
June 21, 2012 — A class action suit has been filed against St. Jude Medical Inc. on behalf of purchasers of the company's defibrillator leads. The Riata and Riata ST electrical wire leads were observed to wear through the silicone casing meant to contain them, going on to protrude into the body.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 21, 2012 — Zoll Medical Corporation, a manufacturer of medical devices and related software solutions, announced that Oxford County EMS in Ontario, Canada, is the first emergency service in North America to use a new system that allows rescuers to defibrillate a heart without stopping chest compressions for defibrillation.
June 21, 2012 — TriReme Medical Inc. (TMI) announced today that it has received U.S. Food and Drug Administration (FDA) clearance for an expanded matrix of sizes for its Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter.
June 21, 2012 — Surefire Medical Inc. announced that it has received 510(k) U.S. Food and Drug Administration (FDA) clearance to market the Surefire high-flow microcatheter, the next generation of the company's novel infusion technology. The Surefire system is designed to deliver therapy with higher infusion efficiency than conventional microcatheters.